Neurodegenerative Disease Market Report 2026
Download Free Sample Buy Now
Neurodegenerative Disease Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Neurodegenerative Disease Market Report 2026

Global Outlook – By Disease Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Amyotrophic Lateral Sclerosis), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Acetylcholinesterase (AChE) Inhibitors, Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitor, Selective Serotonin Reuptake Inhibitor (SSRIs), Other Drug Types), By Route of Administration (Oral, Injectable, Transdermal, Other Routes Of Administration), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels), By End-User (Hospital, Retail, Online) – Market Size, Trends, Strategies, and Forecast to 2035

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Neurodegenerative Disease Market Overview

• Neurodegenerative Disease market size has reached to $57.23 billion in 2025

• Expected to grow to $88.5 billion in 2030 at a compound annual growth rate (CAGR) of 9%

• Growth Driver: Increase In Clinical Trial Activity Fueling The Growth Of The Market Due To Rising Research Investments

• Market Trend: Emergence Of Real-time Personalized Treatments Enhancing Patient Outcomes

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Neurodegenerative Disease Market?

Neurodegenerative disease refers to a group of disorders characterized by the progressive degeneration of the structure and function of the nervous system, including the brain and spinal cord. Its primary goal is to understand, diagnose, and treat these conditions through advancements in biotechnology, pharmaceuticals, and medical technology. This field aims to slow disease progression, improve patient outcomes, and reduce the healthcare burden. It supports aging populations, enhances neurological care, and contributes to a sustainable, technology-driven healthcare system.

The main types of neurodegenerative diseases are parkinson's disease, alzheimer's disease, multiple sclerosis, Huntington's disease, and amyotrophic lateral sclerosis. Parkinson's disease is a progressive neurological disorder that affects movement control due to the loss of dopamine-producing brain cells. These conditions are treated using various types of drugs such as N-methyl-D-aspartate (NMDA) receptor antagonists, cholinesterase inhibitors, dopamine agonists, and immunomodulatory drugs. The routes of administration include oral, injectable, transdermal, and other methods. These drugs are distributed through various channels, including hospital pharmacies, retail pharmacies, online pharmacies, and other distribution channels. The key end-users are hospitals, retail providers, and online platforms.

Neurodegenerative Disease Market Global Report 2026 Market Report bar graph

What Is The Neurodegenerative Disease Market Size and Share 2026?

The neurodegenerative disease market size has grown strongly in recent years. It will grow from $57.23 billion in 2025 to $62.59 billion in 2026 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to limited understanding of disease pathology, reliance on conventional symptomatic treatments, growing aging population, increasing healthcare infrastructure for neurology, limited availability of advanced diagnostic tools.

What Is The Neurodegenerative Disease Market Growth Forecast?

The neurodegenerative disease market size is expected to see strong growth in the next few years. It will grow to $88.5 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to advancements in gene and cell therapy, rising r&d in novel neuroprotective drugs, expansion of clinical trial networks, integration of ai for early diagnosis and patient monitoring, increasing adoption of personalized medicine approaches. Major trends in the forecast period include rising prevalence of neurodegenerative disorders, increasing investment in drug development and clinical trials, adoption of targeted and personalized therapies, growth in awareness and early diagnosis programs, expansion of home-based and outpatient care solutions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Neurodegenerative Disease Market Segmentation

1) By Disease Type: Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Amyotrophic Lateral Sclerosis

2) By Drug Type: N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Acetylcholinesterase (AChE) Inhibitors, Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitor, Selective Serotonin Reuptake Inhibitor (SSRIs), Other Drug Types

3) By Route of Administration: Oral, Injectable, Transdermal, Other Routes Of Administration

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

5) By End-User: Hospital, Retail, Online

Subsegments:

1) By Parkinson's Disease: Idiopathic Parkinson's Disease, Familial Parkinson's Disease, Early-Onset Parkinson's Disease, Parkinsonism

2) By Alzheimer's Disease: Early-Onset Alzheimer's Disease, Late-Onset Alzheimer's Disease, Familial Alzheimer's Disease (FAD), Inflammatory Subtype, Non-Inflammatory Subtype, Cortical Subtype

3) By Multiple Sclerosis (MS): Clinically Isolated Syndrome (CIS), Relapsing-Remitting MS (RRMS), Secondary Progressive MS (SPMS), Primary Progressive MS (PPMS), Progressive-Relapsing MS (PRMS)

4) By Huntington's Disease: Adult-Onset Huntington's Disease, Juvenile Huntington's Disease

5) By Amyotrophic Lateral Sclerosis (ALS): Classical ALS, Limb-Onset ALS, Bulbar-Onset ALS, Respiratory-Onset ALS, Primary Lateral Sclerosis (PLS), Progressive Muscular Atrophy (PMA), Juvenile ALS, ALS-Parkinsonism-Dementia Complex (ALS-PDC)

What Is The Driver Of The Neurodegenerative Disease Market?

The increase in research and clinical trials is expected to propel the growth of the neurodegenerative disease market going forward. Clinical trials refer to research studies conducted with human participants to evaluate the safety, efficacy, and potential side effects of new treatments, drugs, or medical devices. The increase in research and clinical trials is primarily driven by the rising demand for new treatments to address evolving healthcare needs and improve patient outcomes. Clinical trials support neurodegenerative disease research by providing critical data on the safety and effectiveness of new treatments, helping to advance therapeutic development and improve patient outcomes. For instance, in December 2024, according to a report published by the Association of the British Pharmaceutical Industry (ABPI), a UK-based association, the number of UK industry clinical trials initiated rose by 3.7% in 2023 compared to 2022. Therefore, the increase in research and clinical trials is expected to propel the growth of the neurodegenerative disease industry.

Key Players In The Global Neurodegenerative Disease Market

Major companies operating in the neurodegenerative disease market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, AbbVie Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck & Co. Inc., Biogen Inc., Neurocrine Biosciences Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Cassava Sciences Inc., Denali Therapeutics Inc., Voyager Therapeutics Inc., AC Immune SA, Amylyx Pharmaceuticals Inc., Sage Therapeutics Inc., Alzheon Inc.

Global Neurodegenerative Disease Market Trends and Insights

Major companies operating in the neurodegenerative disease market are focusing on developing innovative products such as next-generation adaptive Deep Brain Stimulation (aDBS) systems, aiming to improve treatment precision, enhance disease-modifying effects, and increase patient quality of life. Next generation adaptive deep brain stimulation (aDBS) systems are advanced neurostimulation devices designed to provide real-time, personalized treatment for Parkinson's disease by dynamically adjusting stimulation parameters based on neural feedback, optimizing therapeutic effects, and minimizing side effects for improved patient outcomes. For instance, in February 2025, Medtronic, a US-based medical technology company, received approval from the U.S. Food and Drug Administration (USFDA) for the world's first adaptive deep brain stimulation (aDBS) system for Parkinson's disease. This approval pertains to the premarket approval (PMA) application for the Percept RC neurostimulator with BrainSense technology, which automatically adjusts therapy in response to a patient's brain signals. The system is clinically validated to provide symptom relief for advanced Parkinson's disease patients and represents a significant advancement in personalized neuromodulation therapies.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Neurodegenerative Disease Market?

In December 2024, AbbVie, a US-based biopharmaceutical company, acquired Aliada Therapeutics for an undisclosed amount. With this acquisition, AbbVie aims to advance potentially disease-modifying therapies for Alzheimer’s disease and strengthen its neuroscience pipeline by leveraging Aliada’s novel blood-brain barrier-crossing drug delivery platform. Aliada Therapeutics is a US-based company that develops precision medicines for neurological conditions.

Regional Insights

North America was the largest region in the neurodegenerative disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Neurodegenerative Disease Market?

The neurodegenerative disease market consists of revenues earned by entities through services such as biotechnology research, pharmaceutical development, diagnostic solutions, medical technologies, and patient care advancements aimed at understanding, diagnosing, and treating neurodegenerative conditions. The market value includes the value of related goods sold by the service provider or included within the service offering. The neurodegenerative disease market also includes sales of pharmaceuticals, biotechnology treatments, medical devices, and diagnostic tools aimed at managing and treating neurodegenerative conditions. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Neurodegenerative Disease Market Report 2026?

The neurodegenerative disease market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the neurodegenerative disease industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Neurodegenerative Disease Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $62.59 billion
Revenue Forecast In 2035 $88.5 billion
Growth Rate CAGR of 9.4% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Disease Type, Drug Type, Route of Administration, Distribution Channel, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, AbbVie Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck & Co. Inc., Biogen Inc., Neurocrine Biosciences Inc., Alnylam Pharmaceuticals Inc., Ionis
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Neurodegenerative Disease Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Neurodegenerative Disease Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Neurodegenerative Disease Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Neurodegenerative Disease Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences

4.2. Major Trends

4.2.1 Rising Prevalence Of Neurodegenerative Disorders

4.2.2 Increasing Investment In Drug Development And Clinical Trials

4.2.3 Adoption Of Targeted And Personalized Therapies

4.2.4 Growth In Awareness And Early Diagnosis Programs

4.2.5 Expansion Of Home-Based And Outpatient Care Solutions

5. Neurodegenerative Disease Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Neurology Clinics

5.3 Pharmaceutical And Biotechnology Companies

5.4 Research Institutions

5.5 Home Healthcare Providers

6. Neurodegenerative Disease Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Neurodegenerative Disease Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Neurodegenerative Disease PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Neurodegenerative Disease Market Size, Comparisons And Growth Rate Analysis

7.3. Global Neurodegenerative Disease Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Neurodegenerative Disease Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Neurodegenerative Disease Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Neurodegenerative Disease Market Segmentation

9.1. Global Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, Amyotrophic Lateral Sclerosis

9.2. Global Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, Acetylcholinesterase (AChE) Inhibitors, Antagonist, Monoamine Oxidase B (MAO-B) Inhibitor, Catechol-O-Methyltransferase (COMT) Inhibitor, Selective Serotonin Reuptake Inhibitor (SSRIs), Other Drug Types

9.3. Global Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Injectable, Transdermal, Other Routes Of Administration

9.4. Global Neurodegenerative Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

9.5. Global Neurodegenerative Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital, Retail, Online

9.6. Global Neurodegenerative Disease Market, Sub-Segmentation Of Parkinson's Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Idiopathic Parkinson's Disease, Familial Parkinson's Disease, Early-Onset Parkinson's Disease, Parkinsonism

9.7. Global Neurodegenerative Disease Market, Sub-Segmentation Of Alzheimer's Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Early-Onset Alzheimer's Disease, Late-Onset Alzheimer's Disease, Familial Alzheimer's Disease (FAD), Inflammatory Subtype, Non-Inflammatory Subtype, Cortical Subtype

9.8. Global Neurodegenerative Disease Market, Sub-Segmentation Of Multiple Sclerosis (MS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Clinically Isolated Syndrome (CIS), Relapsing-Remitting MS (RRMS), Secondary Progressive MS (SPMS), Primary Progressive MS (PPMS), Progressive-Relapsing MS (PRMS)

9.9. Global Neurodegenerative Disease Market, Sub-Segmentation Of Huntington's Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult-Onset Huntington's Disease, Juvenile Huntington's Disease

9.10. Global Neurodegenerative Disease Market, Sub-Segmentation Of Amyotrophic Lateral Sclerosis (ALS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Classical ALS, Limb-Onset ALS, Bulbar-Onset ALS, Respiratory-Onset ALS, Primary Lateral Sclerosis (PLS), Progressive Muscular Atrophy (PMA), Juvenile ALS, ALS-Parkinsonism-Dementia Complex (ALS-PDC)

10. Neurodegenerative Disease Market Regional And Country Analysis

10.1. Global Neurodegenerative Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Neurodegenerative Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Neurodegenerative Disease Market

11.1. Asia-Pacific Neurodegenerative Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Neurodegenerative Disease Market

12.1. China Neurodegenerative Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Neurodegenerative Disease Market

13.1. India Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Neurodegenerative Disease Market

14.1. Japan Neurodegenerative Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Neurodegenerative Disease Market

15.1. Australia Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Neurodegenerative Disease Market

16.1. Indonesia Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Neurodegenerative Disease Market

17.1. South Korea Neurodegenerative Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Neurodegenerative Disease Market

18.1. Taiwan Neurodegenerative Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Neurodegenerative Disease Market

19.1. South East Asia Neurodegenerative Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Neurodegenerative Disease Market

20.1. Western Europe Neurodegenerative Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Neurodegenerative Disease Market

21.1. UK Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Neurodegenerative Disease Market

22.1. Germany Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Neurodegenerative Disease Market

23.1. France Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Neurodegenerative Disease Market

24.1. Italy Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Neurodegenerative Disease Market

25.1. Spain Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Neurodegenerative Disease Market

26.1. Eastern Europe Neurodegenerative Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Neurodegenerative Disease Market

27.1. Russia Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Neurodegenerative Disease Market

28.1. North America Neurodegenerative Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Neurodegenerative Disease Market

29.1. USA Neurodegenerative Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Neurodegenerative Disease Market

30.1. Canada Neurodegenerative Disease Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Neurodegenerative Disease Market

31.1. South America Neurodegenerative Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Neurodegenerative Disease Market

32.1. Brazil Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Neurodegenerative Disease Market

33.1. Middle East Neurodegenerative Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Neurodegenerative Disease Market

34.1. Africa Neurodegenerative Disease Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Neurodegenerative Disease Market, Segmentation By Disease Type, Segmentation By Drug Type, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Neurodegenerative Disease Market Regulatory and Investment Landscape

36. Neurodegenerative Disease Market Competitive Landscape And Company Profiles

36.1. Neurodegenerative Disease Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Neurodegenerative Disease Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Neurodegenerative Disease Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.3. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Neurodegenerative Disease Market Other Major And Innovative Companies

Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck & Co. Inc., Biogen Inc., Neurocrine Biosciences Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Cassava Sciences Inc., Denali Therapeutics Inc., Voyager Therapeutics Inc., AC Immune SA, Amylyx Pharmaceuticals Inc., Sage Therapeutics Inc., Alzheon Inc.

38. Global Neurodegenerative Disease Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Neurodegenerative Disease Market

40. Neurodegenerative Disease Market High Potential Countries, Segments and Strategies

40.1 Neurodegenerative Disease Market In 2030 - Countries Offering Most New Opportunities

40.2 Neurodegenerative Disease Market In 2030 - Segments Offering Most New Opportunities

40.3 Neurodegenerative Disease Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Neurodegenerative Disease Market, Overview Of Key Products - Product Examples
  • Table 2: Global Neurodegenerative Disease Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Neurodegenerative Disease Market, Supply Chain Analysis
  • Table 4: Global Neurodegenerative Disease Market, Major Raw Material Providers
  • Table 5: Global Neurodegenerative Disease Market, Major Resource Providers
  • Table 6: Global Neurodegenerative Disease Market, Major Manufacturers (Suppliers)
  • Table 7: Global Neurodegenerative Disease Market, Major Distributors And Channel Partners
  • Table 8: Global Neurodegenerative Disease Market, Key Technologies & Future Trends
  • Table 9: Global Neurodegenerative Disease Market, Major Trends
  • Table 10: Global Neurodegenerative Disease Market, Major End Users
  • Table 11: Global Neurodegenerative Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Neurodegenerative Disease Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Neurodegenerative Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Neurodegenerative Disease Market - TAM, US$ Billion, 2025
  • Table 15: Global Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Neurodegenerative Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Neurodegenerative Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Neurodegenerative Disease Market, Sub-Segmentation Of Parkinson's Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Neurodegenerative Disease Market, Sub-Segmentation Of Alzheimer's Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Neurodegenerative Disease Market, Sub-Segmentation Of Multiple Sclerosis (MS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Neurodegenerative Disease Market, Sub-Segmentation Of Huntington's Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Neurodegenerative Disease Market, Sub-Segmentation Of Amyotrophic Lateral Sclerosis (ALS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Neurodegenerative Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Neurodegenerative Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Global Neurodegenerative Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 100: Global Neurodegenerative Disease Market - Company Scoring Matrix
  • Table 101: Pfizer Inc. Financial Performance
  • Table 102: Johnson & Johnson Financial Performance
  • Table 103: F. Hoffmann-La Roche Ltd Financial Performance
  • Table 104: AbbVie Inc. Financial Performance
  • Table 105: Sanofi S.A. Financial Performance
  • Table 106: Global Neurodegenerative Disease Market, Competitive Benchmarking (In USD Billions)
  • Table 107: Global Neurodegenerative Disease Market, Competitive Dashboard
  • Table 108: Global Neurodegenerative Disease Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 109: Global, Neurodegenerative Disease Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030
  • Table 110: Global, Neurodegenerative Disease Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030
  • Table 111: Global, Neurodegenerative Disease Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

List Of Figures

    Figure 1: Global Neurodegenerative Disease Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Neurodegenerative Disease Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Neurodegenerative Disease Market, Supply Chain Analysis
  • Figure 4: Global Neurodegenerative Disease Market, Major Raw Material Providers
  • Figure 5: Global Neurodegenerative Disease Market, Major Resource Providers
  • Figure 6: Global Neurodegenerative Disease Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Neurodegenerative Disease Market, Major Distributors And Channel Partners
  • Figure 8: Global Neurodegenerative Disease Market, Key Technologies & Future Trends
  • Figure 9: Global Neurodegenerative Disease Market, Major Trends
  • Figure 10: Global Neurodegenerative Disease Market, Major End Users
  • Figure 11: Global Neurodegenerative Disease Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Neurodegenerative Disease Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Neurodegenerative Disease Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Neurodegenerative Disease Market - TAM, US$ Billion, 2025
  • Figure 15: Global Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Neurodegenerative Disease Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Neurodegenerative Disease Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Neurodegenerative Disease Market, Sub-Segmentation Of Parkinson's Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Neurodegenerative Disease Market, Sub-Segmentation Of Alzheimer's Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Neurodegenerative Disease Market, Sub-Segmentation Of Multiple Sclerosis (MS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Neurodegenerative Disease Market, Sub-Segmentation Of Huntington's Disease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Neurodegenerative Disease Market, Sub-Segmentation Of Amyotrophic Lateral Sclerosis (ALS), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Neurodegenerative Disease Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Neurodegenerative Disease Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Neurodegenerative Disease Market, Segmentation By Disease Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Neurodegenerative Disease Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Neurodegenerative Disease Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Global Neurodegenerative Disease Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 100: Global Neurodegenerative Disease Market - Company Scoring Matrix
  • Figure 101: Pfizer Inc. Financial Performance
  • Figure 102: Johnson & Johnson Financial Performance
  • Figure 103: F. Hoffmann-La Roche Ltd Financial Performance
  • Figure 104: AbbVie Inc. Financial Performance
  • Figure 105: Sanofi S.A. Financial Performance
  • Figure 106: Global Neurodegenerative Disease Market, Competitive Benchmarking (In USD Billions)
  • Figure 107: Global Neurodegenerative Disease Market, Competitive Dashboard
  • Figure 108: Global Neurodegenerative Disease Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 109: Global, Neurodegenerative Disease Market Size Gain ($ Billion), Segmentation By Disease Type, 2025 – 2030
  • Figure 110: Global, Neurodegenerative Disease Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030
  • Figure 111: Global, Neurodegenerative Disease Market Size Gain ($ Billion), Segmentation By Route of Administration, 2025 – 2030

Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Read More About Advanced Therapy Medicinal Products Industry Poised for Rapid Expansion, Projected to Hit $104.43 Billion by 2029

Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

Read More About Global Insights: Androgen Deprivation Therapy Market Expected to Surpass $10.49 Billion by 2029

2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Anti-CD20 Monoclonal Antibodies Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Read More About Future Projections: Anti-D Immunoglobulin Market to Reach $3.34 Billion by 2029 at 6.6% CAGR

Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Anti-Inflammatory Biologics Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Read More About CAGR of 10.8% Projected for Anti-Tumor Drugs Market From 2025 to 2029

Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Read More About Future Demand and Leading Companies Shaping the Asthma Disease Market to 2029

Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Read More About Comprehensive Forecast: Asthma Therapeutics Market Share, Growth, and Opportunities Through 2029

Central Nervous System Drugs Global Market Report 2022 – By Type (Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores), By Route O...

Brain Health Supplements Market Report 2026 - Global Outlook – By Product (Natural Molecules, Herbal Extract, Vitamins And Minerals), By Supplement Form (Tablets, Capsules, Liquid), By Distribution (Supermarket and Hyper...

Rare Neurological Disease Treatment Market Report 2026 - Global Outlook – By Drug Type (Biologics, Small Molecules), By Therapy (Cognitive Behavioral Therapy, Interpersonal Psychotherapy, Disease-Modifying Neurological T...

Degenerative Disc Disease Treatment Market Report 2026 - Global Outlook – By Type (Conventional Drugs, Novel Therapies), By Route Of Administration (Oral, Injectable), By End User (Hospitals, Ambulatory Surgical Centers,...

Neurological Disorder Drugs Market Report 2026 - Global Outlook – By Drug Class (Cholinesterase Inhibitors, N-Methyl-D-Aspartate (NMDA) Receptor Antagonists, Antiepileptic, Antipsychotic And Antidepressant, Other Drugs C...

Neurofibromatosis Treatment Market Report 2026 - Global Outlook – By Type (Neurofibromatosis 1 (NF1), Neurofibromatosis 2 (NF2), Schwannomatosis), By Treatment (Medications, Surgery, Radiation Therapy, Other Treatments),...

Neurological Biomarkers Market Report 2026 - Global Outlook – By Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Other Products), By Application (Alzheimer’s Disease, Parkins...

Generic Central Nervous System Drugs Market Report 2026 - Global Outlook – By Type (Multiple Sclerosis (MS), Anti-Psychotic, Analgesics, Anti-Parkinson Drugs, Anesthetics, Anti-Epileptics, Anti-Depressants, Other Types),...

Frequently Asked Questions

The Neurodegenerative Disease market was valued at $57.23 billion in 2025, increased to $62.59 billion in 2026, and is projected to reach $88.5 billion by 2030.

The global Neurodegenerative Disease market is expected to grow at a CAGR of 9.0% from 2026 to 2035 to reach $88.5 billion by 2035.

Some Key Players in the Neurodegenerative Disease market Include, Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, AbbVie Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck & Co. Inc., Biogen Inc., Neurocrine Biosciences Inc., Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., Cassava Sciences Inc., Denali Therapeutics Inc., Voyager Therapeutics Inc., AC Immune SA, Amylyx Pharmaceuticals Inc., Sage Therapeutics Inc., Alzheon Inc. .

Major trend in this market includes: Emergence Of Real-time Personalized Treatments Enhancing Patient Outcomes. For further insights on this market. request a sample here

North America was the largest region in the neurodegenerative disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the neurodegenerative disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us